Reduced Intensity Conditioning for Haploidentical Bone Marrow Transplantation in Patients with Symptomatic Sickle Cell Disease
The researchers are doing this study to learn if a new type of transplant is safe and effective to treat Severe Sickle Cell Disease (SCD).
This study is being done to learn if a new type of allogeneic transplant called a haploidentical transplant is safe and effective to treat Sickle Cell Disease (SCD).
Participants will be compensated for their participation.
- IRB Number: 1711207951 (BMTCTN1507)
- Research Study Identifier: TX8873
- Principal Investigator: Sherif Farag, MD
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required